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ABSTRACT: Leishmaniasis is a chronic disease caused by protozoa of the
distinct Leishmania genus transmitted by sandflies of the genus Phlebotomus (old
world) and Lutzomyia (new world). Among the molecular factors that contribute
to the virulence and pathogenesis of Leishmania are metalloproteases, e.g.,
glycoprotein 63 (gp63), also known as leishmanolysin or major surface protease
(MSP). This protease is a zinc-dependent metalloprotease that is found on the
surface of the parasite, abundant in Leishmania promastigote and amastigote. This
study describes the prediction of three-dimensional (3D) structures of
leishmanolysin (UniProt ID A0A088RJX7) of Leishmania panamensis employing
a homology modeling approach. The 3D structure prediction was performed using
the SWISS-MODEL web server. The tools PROCHECK, Molprobyty, and
Verify3D were used to check the quality of the model, indicating that they are
reliable. Best docking configurations were identified applying AutoDock Vina in
PyRx 0.8 to obtain a potential antileishmanial activity. Biflavonoids such as lanaroflavone, podocarpusflavone A, amentoflavone, and
podocarpusflavone B showed good scores among these molecules. Lanaroflavone appears to be the most suitable compound from
binding affinity calculations.
1. INTRODUCTION
Leishmaniases, a neglected spectrum of diseases considered to
have negative implications and many consequences, are caused
by protozoa parasites of the genus Leishmania,1 transmitted by
female sandflies of Phlebotomus (old world) and Lutzomyia
(new world) as its vector. The Leishmania species are generally
zoonotic and carried by rodents and canines, which are their
main reservoir hosts.2 The Leishmania parasites infect 10−12
million people worldwide, causing a spectrum of diseases
known as leishmaniases. It has been estimated that 350 million
people are at the risk of contracting leishmaniasis, and 2
million cases are reported each year.3 Some scientific advances
have been achieved in the treatment, diagnosis, and prevention
of leishmaniasis in the last 10 years, and the costs of several key
medicines have been reduced.4 Conventional chemotherapeu-
tics for leishmaniasis are based on antimonial sodium
stibogluconate (Pentostam), miltefosine (Miltex), and meglu-
mine antimoniate (Glucantime). There are adverse side effects
associated with the compounds, and drug resistance is
emerging. However, these medications are not very effective
or available, with some reports describing the toxic effects of
drugs in patients. Researchers have observed that there is an
increased incidence of multidrug resistance (MDR) in
leishmaniasis. The absence of vaccines has led to attention
being focused on the identification of novel targets and the
development of an alternative drug. Therefore, the develop-
ment of novel agents against these parasites is extremely
significant.5,6
Many important enzymes are present in the Leishmania
parasite, which are considered potential targets for the
development of new therapeutic agents. Among the enzymes
of Leishmania are metalloproteases, especially those belonging
to metzincins, which contain zinc atoms in their structure, like
the so-called leishmanolysin.7 Glycoprotein 63 (gp63) or
leishmanolysin is a 63 kDa protein and a metalloprotease from
the M8 family (subclan MA(M), metzincins), which
contributes to the virulence and pathogenesis of the
Leishmaniaparasite and is found on its surface.8 It was isolated
for the first time in 1980 and described genetically and
biochemically as a surface antigen expressed in promastigotes
of the Leishmania species, having a range of substrates,
including casein, gelatin, albumin, hemoglobin, and fibrino-
gen.7 The components of this protease include a sequence
motif HExxHxxGxxH and an N-terminal propeptide, which
renders the proenzyme inactive in the course of the translation
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and is eliminated during the maturation and activation. gp63 is
the most abundant surface protein of promastigotes and
contains 1% of the total parasite proteome but is upregulated
in amastigotes.9,10 gp63 has been reported to interact with the
fibronectin receptor and therefore could further aid the
adherence of the parasite to macrophages.11 From these
diverse findings, it is clear that by cleavage and/or degradation
of various proteins, gp63 can profoundly affect the macrophage
functions, favoring the survival of Leishmania.12,13
Even though glycoproteins have been one of the most
important targets of the Leishmania parasite, few relevant
studies with glycoprotein have been performed. In the search
for new drugs for the treatment of leishmaniasis, Shaukat et
al.14 conducted a study of benzimidazole derivatives, whose
results both in vitro and in silico through molecular docking
showed that these compounds could serve as the basis for the
future treatment of leishmaniasis.14
Computational methods have been successfully applied to
predict protein structures and ligand−protein interactions.
Molecular docking is a method that is used to predict the
preferred orientation of predominantly small organic molecules
(ligands) within biological macromolecules (proteins). In this
sense, natural products can be a valuable alternative to provide
huge diversity of chemical structures for biological screening
tests of Leishmania species; flavonoids are promising drug
candidates for the treatment of all forms of leishmaniasis.15
This study reports a three-dimensional (3D) structure of the
leishmanolysin protein, gp63, from Leishmania panamensis that
was built through homologous modeling and optimized using
molecular dynamics (MD) simulation. The leishmanolysin
protein from L. major (ID PDB: 1LML) was used as a
template. The structure was validated to check the quality of
the models, indicating that they are reliable. Based on the 3D
structure, the ligand-binding modes of flavonoid compounds
were elucidated using molecular docking in proteins both
crystallized and built by homology modeling. The docking
analysis revealed that gp63 from L. major and L. panamensis
can structurally accommodate various flavonoid-like ligands
and helped us in the molecular recognition of the design of the
possible inhibitors and provided new knowledge that can be
used to treat the disease caused by the Leishmania species.
2. RESULTS AND DISCUSSION
2.1. Homology Model. The structural models of
leishmanolysin from L. panamensis were built by comparative
modeling using the crystal structure of gp63 of L. major (PDB
ID: 1LML) as the template (Figure 1).
The alignment (Figure S1) between leishmanolysin proteins
of L. major and L. panamensis indicated the presence of
conserved regions throughout the protein under study. The
structures were selected based on their similarity, identity, and
number of gaps. The alignment is consistent with the
experimental results. The comparison with the L. major
leishmanolysin sequence showed the identity displayed
74.8% with Lpgp63.
These results are within the range of 59−71% reported
previously by Sutter et al. for a variety of L. major
leishmanolysin proteins coded by chromosome 10.16 The
HEXXHXXGXXH motif of the active site, typical of the zinc-
dependent metalloproteinases, is highly conserved. There is an
insertion of 62 residues between glycine and the third histidine
in each of the proteins modeled for the Leishmania species, as
reported by Yao et al.8 The position of the active site is
highlighted with two of the histidines being part of the α-helix
(H8) and the other in a loop in the central domain. The zinc
atom of the protein lies between the N-terminal and central
domains. The alignment is consistent with experimental
outcomes reporting that nine disulfide bridges in the template
structure are completely aligned with the leishmanolysin
sequence.17 The high conservation of the sequence is also
reflected in the similarity of some properties.
2.2. Molecular Dynamics Simulation. Molecular dy-
namics simulations were employed to optimize and establish
the stability of the protein constructed by homology modeling.
The MD trajectory was analyzed by computing the root-mean-
square deviation (RMSD) of Cα (Figure 2A). The molecular
system reached stable states during 200 ns simulations.
The leishmanolysin of L. major, 1LML protein, converged in
the time frame after 200 ns of MD simulation. The average
RMSD value was 1.482 Å ± 0.103, and these outcomes were
similar to those reported by Sutter et al. For the protein that
was built by homology, Lpgp63, the final equilibrium was
reached in the MD simulation with an average of 1.909 Å ±
0.207 nm.
The root-mean-square fluctuation (RMSF) values of the
modeled structures generated during the MD simulation were
calculated to characterize the mobility of particular residues
(Figure 2B). As expected, the RMSF plot shows a variation in
amino acid residues between the different leishmanolysin
proteins of L. major and L. panamensis. In the model, the
greatest fluctuations were observed in the N- and C-terminal
Figure 1. Homology model of leishmanolysin. The template structure
of L. major (PDB ID: 1LML) is color coded in cyan (A) and the
homology model of L. panamensis (lpgp63) is shown in red (B). (C)
Superimposition of the homology model with the template. The
active site and the zinc atom (gray) are highlighted in the squares on
the right-hand side.
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domains, while the central domain where the active site is
located remains rigid, as reported by Bianchini et al.18 On the
other hand, are evidenced mainly in the change of the length of
the amino acids in the active site concerning the zinc atom. It
is observed in this study that the bond distance of zinc to the
Nε2 atoms of HIS residues undergoes variations.17−19 It is
additionally mentioned that the zinc atom shortens its distance
to the OE2 of the GLU residue (Figure S2).
A Ramachandran plot was built, and it showed that 92.1 and
91.1% of residues were in the most favored regions and 7.1 and
8% were in the additional allowed regions. After the MD
refinement, a checking process was also undertaken. The
Ramachandran plot of the 1LML protein and model built by
homology showed that 96.0 and 96.3% of residues were found
in the most favored allowed regions and 4 and 3.7% were in
the additional allowed region (Figure S3). Rodriguez et al.
report that the homology model of L. braziliensis shows
percentage of residues in favorable regions very similar to those
reported in this article for the study of leishmanolysin.20,21
The analysis of the models with ProSA-web service shows a
Z-score between −8.27 and −9.81 (acceptable values are
below 0.5). The global score was between −0.98 and −1.49.
Otherwise, the quality of the models was confirmed by the
Verify3D analysis in an average of 91% of the residues with a
score >2 in the 3D/one-dimensional (1D) profile.
2.3. Molecular Docking. Molecular docking has been
implemented to reveal the interaction between flavonoid
compounds and leishmanolysin proteins of L. major and L.
panamensis. Table 1 shows 24 flavonoid molecules to have the
lowest binding energy docked at the active site for the two
leishmanolysin proteins of L. major and L panamensis,
respectively. The chemical structures are indicated in the
Supporting Information, Table S1. Inspection of the docked
structures shows the most favorable interactions within the
active site, particularly between hydrogen bonds and hydro-
phobic interactions.
Docking of selected ligand molecules and reference
compounds onto the binding site (pocket) of the leishmano-
lysin (gp63) protein and the homologous protein constructed
was performed by AutoDock Vina in the PyRx 0.8 module.
After that, for each molecule, the best pose based on its
conformation and docking binding energy was selected. Since
leishmanolysin structures do not contain a co-crystallized
ligand, the study was conducted employing the active site
reported by Schlagenhouf et al.10 The binding site comprised
amino acids HIS264, GLU265, HIS268, HIS334, and MET345
and a Zn atom, and the grid box was centered on these
residues. As reported by Shaukat et al.,14 amphotericin B was
also used as a reference molecule. The antiparasitic activity of
amphotericin B is related to the ability of this antibiotic to
form permeable channels in the cellular membrane of the
pathogen. These channels cause a leakage of monovalent ions
and small organic molecules from the cellular membrane.14,22
In both amastigotes and promastigotes, leishmanolysin is
present on the surface, and it is possible that amphotericin will
interact with this protein. The docking performed with the
antibiotic using the gp63 protein showed that it interacts with
the amino acids GLU220 and GLU265 and the Zn atom for
the case of gp63 of L. major. The proteins constructed by the
homology of L. panamensis follow the same scheme described
above (GLU218, GLU263, and Zn) (Figure S4).
The docking pose of lanaroflavone exhibited the lowest
binding affinity, followed by podocarpusflavone A, amento-
Figure 2. Optimization of the homology model by MD simulations.
(A) Cα RMSD values of proteins 1LML (cyan) and lpgp63 (red) of
L. major and L. panamensis, respectively, were plotted. (B) Root-
mean-square fluctuation (RMSF) values of particular residues.
Comparison along a 200 ns MD simulation.
Table 1. Binding Affinity (kcal/mol) of the Most Interesting
Compounds Obtained by Docking with Different
Leishmanolysin of the Leishmania Species
molecule 1LML Lpgp63
amphotericin B −11.5 −10.7
lanaroflavone −10.5 −9.9
podocarpusflavone A −10.1 −9.7
amentoflavone −9.9 −9.7
podocarpusflavone B −9.6 −9.1
pseudotsuganol −9.5 −9.2
tetrahydrorobustaflavone −9.4 −9.7
2,3-dehydrosilibinin −8.7 −8.3
rhuschalcone VI −8.6 −8.4
epigallocatechin −8.6 −7.3
agathisflavone −8.4 −8.6
SN00000577 −8.4 −7.2
methyltetrahydroamentoflavone −8,4 −8.5
SN00000355 −8.4 −6.4
SN00000558 −8.3 −7.2
abyssinone IV −8.2 −7.6
quercitrin −8.2 −7.5
SN00000365 −8.2 −7.2
4-hidroxylonchocarpine −8.1 −7,2
(α-naphthoflavone) SN00000328 −8.1 −7.3
bipinnatone A −8.0 −6.5
medicagenina −8.0 −7.5
SN00000367 −8.0 −7.3
SN00000357 −8.0 −6.8
SN00157618 −8.0 −8.1
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flavone, and podocarpusflavone B when docking was
performed with 1LML and Lpgp63 (Figure 3). The most
significant interactions between the ligands and proteins were
hydrophobic, H-bonding, metal-contact, and π-stacking (π−π
T-shaped) interactions. Table 2 summarizes the principal
interactions between the first four ligands with the lowest
binding affinity and each of the proteins studied. Lanaro-
flavone, podocarpusflavone, and amentoflavone formed an H-
bond with residues LEU224, ALA225, SER418, and GLN341
within the active site, while podocarpusflavone B interacted
with GLY222, SER418, and SER465 through H-bonds. All
ligands presented hydrophobic links, especially π-stacking, with
VAL261, HIS264, LEU257, PRO460, and ALA350 with the
rings of biflavonoid compounds. Podocarpusflavone B
Figure 3. Docking poses of the binding interaction of molecules in the active site of leishmanolysin from L. major: (A) lanoraflavone, (B)
amentoflavone, (C) podocarpusflavone A, and (D) podocarpusflavone B.
Table 2. H-Bond Interaction Information from Docking Calculations between Ligands and Modeled Proteins
1LML Lpgp63
molecule H-bond distance (Å) H-bond distance (Å)
LEU224 NH···OC-4 1.98 LEU222 NH···CO-4 3.00
ALA225 CO···OH-5 2.80 ALA223 CO···OH-5 2.24
amentoflavone ALA349 NH···O-1 2.19 ASP416 O···OH-5″ 2.80
SER448 OH···OH-4‴ 2.31
THR459 OH···CO-4″ 2.77
THR459 OH···OH-5″ 2.80
LEU224 NH···OC-4 1.97 LEU222 NH···CO-4 2.27
ALA225 C0···OH-5 2.49 ALA223 NH···CO-4 2.68
ALA225 NH···OC-4 2.74 ALA223 CO···OH-5 2.65
lanaroflavone HIS264 NH···OH-7 2.81 LYS339 NH···CO-4″ 2.98
ALA346 CO···OH-7 2.92
GLN341 CO···OH-4″ 2.98
ALA349 NH···O-1 2.61
LEU224 NH···OC-4 1.96 LEU222 NH···CO-4 2.02
ALA225 C0···OH-5 2.64 ALA223 CO···OH-5 2.16
podocarpusflavone A ALA349 NH···O-1 2.40
SER418 OH···OH-4″ 2.09
GLY222 CO···OH-5 2.91 LEU222 NH···CO-4 2.01
podocarpusflavone B SER418 OH···OH-4″ 2.44
SER465 OH···OH-4″ 2.77
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interacted with amino acids GLY222, SER418, and SER465
through H-bonds.
An interaction with the zinc atom was observed in
lanoraflavone where the oxygen of the hydroxyl group in
position 7 favorably interacts with this metal. In podocarpus-
flavone A and amentoflavone, the O−metal bond of the same
hydroxyl group in position 7 was favorable, perhaps because of
the distance between the two atoms, while in podocarpus-
flavone B, there was no interaction with the zinc as was
observed.
In the case of leishmanolysin, lpgp63, of L. panamensis
constructed by homology, the four molecules mentioned above
presented the same pattern of interactions as in gp63 of L.
major (Table 2). Lanaroflavone, amentoflavone, and podo-
carpusflavone A and B interact through H-bonds with residues
LEU222, ALA223, and ALA334. Regarding hydrophobic
interactions, the amino acids involved are ILE255, HIS262,
and VAL347. The zinc atom has a metallic interaction with the
hydroxyl group of the flavonoids (Figure 4).
2.4. Solvent-Accessible Surface Area (ASA). Figure
5A,B shows the solvent-accessible surface area for the two
proteins studied, 1LML and lpgp63, respectively. The graph
shows that the docked molecules produce an alteration in the
access to solvent, being more noticeable in amentoflavone. The
HIS264 and GLU265 residues decrease their ASA values with
respect to the native protein. The HIS334 residue does not
show significant changes for lanaroflavone, podocarpusflavone
A, and podocarpusflavone B, while in amentoflavone, the value
of the ASA is drastically decreased. On the other hand, the zinc
atom is also significantly affected when the docked compounds
are compared to the native protein. Table S2 shows the ASA
values for all protein residues that interact with docked
molecules.
2.5. Validation. The molecular docking performed with
each of the models and the crystallographic structure was
validated by the receiver operating characteristic (ROC) curve.
The area under the curve (AUC) for 1LML and LpGp63 was
0.926 ± 0.026 and 0.928 ± 0.017, respectively (Figure S5).
The ROC curve discriminates among active ligands and decoy
structures, indicating the good overall predictive performance
(AUC > 0.5) of docking for the models of lpgp63 and 1LML.
Figure 4. Docking poses of the molecules in the active site of leishmanolysin from L. panamensis built by the homology model: (A) lanoraflavone,
(B) amentoflavone, (C) podocarpusflavone A, and (D) podocarpusflavone B.
Figure 5. Solvent-accessible surface area (ASA) for residues from the
active site and the zinc atom: (A) 1LML and (B) lpgp63.
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Since the calculation of the enrichment factor (EF1%)
represents another method to evaluate the performance of
virtual screening in discriminating active from inactive
compounds, we performed a docking study with a decoy set
including 86 active and 90 inactive molecules. Particularly,
analyzing the top 1% of the ranking obtained by sorting the
scores in ascending order, it was possible to find good EF
values. For 1LML and LpGp63, the EF values were 45 and 44,
respectively, which show that the model demonstrated
sufficient discriminating capability for exploring the top 1%
of docked compounds.
The correlation analysis performed for 32 flavonoids
presented a linear relationship between theoretical free binding
energy (kcal/mol) vs pIC50 for 1LML and the model
developed by homology (Figure S5). Both correlations
indicate a value of R > 0.5. Therefore, we can conclude that
the outcome achieved in the virtual screening with AutoDock
Vina for the two proteins tested was favorable (Table S3).
Flavonoids represent a broad family of polyphenolic
compounds found in vegetables and fruits. It is generally
accepted that these compounds are safe and nontoxic. The
most common flavonoids are flavones and isoflavones.
Naturally occurring flavones have been reported to have
leishmanicidal activity.23 Various flavonoids have demonstra-
ted activity against amastigotes in macrophage infection, such
as quercetin that reduces intracellular load by 70% at 45
μM.15,23
Lanaroflavone has an ether bridge that links two fragments
to form the biflavonoid (bipigenina, C″−O−C−). This allows
its free rotation and the compound can better fit the binding
pocket of the protein. By contrast, a C3′−C8′′ bond present in
the other biflavonoids provides certain rigidity to these
structures and the interaction with the binding pocket is less
favored. Some studies have indicated that the hydroxyl and
methoxyl groups at the rings of flavonoids are involved in their
bioactivities.24−27 Lanaroflavone has a C−4‴−O−C−8
junction that permits better rotation (the substitution of C-
4‴ seems to have higher relevance regarding the antiplasmodial
and leishmanicidal activities).25 However, the C3″−C8′′
interflavonyl linkage of amentoflavone and podocarpusflavone
A and B is more restricted,27 allowing lanaroflavone to be
oriented in the active site of leishmanolysin.
Weniger et al.24 have reported that lanaroflavone exhibited
optimum antiplasmodial activity in vitro. When compared with
the strains of Plasmodium falciparum K1 chloroquine-resistant
presents a moderate antileishmanial activity of L. donovani in
amastigotes with an IC50 of 0.2 and 3.9 μg mL
−1,
respectively.24 In amentoflavone, the substitution of C-4‴
seems to have high relevance for the antiplasmodial and
leishmanicidal activities.25 Little antileishmanial activity
compared to promastigotes in L. donovani was reported for
podocarpusflavone A and B.27 For biflavonoids having a C−C
interflavonyl linkage, there is also a tendency to enhance the
antimalarial activity with increasing number of methoxyl
groups in the molecule, as observed in amentoflavone and in
biflavonoids, such as methyltetrahydroamentoflavone and
podocarpusflavone A, whose methoxy group in position 4″
interacts with the 1LML protein of L. major, as was described
above.28−31 Recently, biflavonoids have come to the forefront
of the polyphenol family for their antituberculosis activities.32
In recent pharmacological studies, they are also reported to
possess antinociceptive, anti-inflammatory, and cytotoxic
properties.33,34 Only a few studies indicate their antiprotozoal
activity, but recently, antiplasmodial activity was established for
two compounds of this kind.
Furthermore, it was found that amentoflavone was not active
on axenic amastigotes of L. donovani in the study by Weniger
et al.,25 and it showed poor activity on promastigotes of the
same species according to del Rayo Camacho et al.27L.
amazonensis displayed excellent antileishmanial activity for
intracellular amastigotes 48 h after the aforementioned
treatment. Therefore, the antileishmanial action of this
compound may be mediated by the host cell. This action
highlights the properties of the compound as a prodrug, which
needs to be metabolized by the cell to exert its effect.35
The molecules pseudotsuganol and rhuschalcone VI have a
binding affinity of −9.6 and −8.7 kcal/mol, respectively. These
two compounds presented activity against L. major. Further, it
was shown that these two molecules exhibit notable attraction
for the nucleoside hydrolase enzyme of Leishmania. Methyl-
tetrahydroamentoflavone (−8.4 kcal/mol) has a positive
interaction energy with L. major methionyl-tRNA synthetase,
according to the same authors.36
The analyzed compounds, in general, demonstrate affinity
for the proteins considered. Although they are molecules of
natural origin, Lipinski’s rules are not so relevant in predicting
their drug-likeness, as reported for other biologically
interesting natural products. We believe that this is because
nature has learned to maintain low hydrophobicity and
intermolecular H-bond donating potential when it needs to
make biologically active compounds with significant molecular
weight and considerable numbers of rotatable bonds. In most
cases, natural products do not necessarily abide by Lipinski’s
rule because they are thought to enter the human body not by
passive diffusion but by more complex mechanisms like active
transportation and hence are not expected to comply with the
rules for bioavailability.37 Besides, natural products are more
likely to resemble biosynthetic intermediates or endogenous
metabolites than purely synthetic compounds and hence take
advantage of active transport mechanisms.
3. CONCLUSIONS
In this study, the 3D structures of different Leishmania spp.
gp63 proteins were constructed by homology modeling using
the crystal structure of leishmanolysin (gp63) of L. major as a
template. The reliability of three models was assessed by
Ramachandran plots, ProSA-web, PROCHECK, Verify3D, and
molprobity. As expected, the resulting structure was similar to
that of the template. The data reported here are in agreement
with what has been suggested by some authors, with the N-
terminal and C-terminal regions being the regions of most
appreciable variation. The findings indicate a more rigid central
domain, although some regions (especially the loop region)
were extremely flexible, despite certain points where protein
mobility was observed.
Docking studies made it possible to predict affinity, activity,
binding, and the orientation of the binding of flavonoids with
leishmanolysin proteins. The analysis was based on the
evaluation of their binding energy. Compounds like flavonoids,
chalcones, and bioflavonoids showed great affinity to the
leishmanolysin protein from L. major. Lanaroflavone, the
molecule with the lowest binding energy, also showed good
antileishmanial activity, despite violating the rule of five
(Lipinski’s rules). Flavonoid derivatives are natural products
that exhibit promising antileishmanial activity and deserve
further research.
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4. EXPERIMENTAL SECTION AND COMPUTATIONAL
METHODS
4.1. Homology Model. The protein sequence of gp63
from L. panamensis was retrieved from the UniProt database.
The Uniprot accession number is A0A088RJX7 with 594
amino acid residues. The crystal structure of gp63 from L.
major, employed as a template, was retrieved from the protein
database PDB (PDB ID: 1LML).10 The model was generated
using the SWISS-MODEL server.38 The best model was
selected based on QMEAN and Z-score of ProSA-web. The
quality of 3D prediction was assessed using Molprobity,39
ProSA-web,40 and Verify3D.41 The final representation was
visualized using Discovery Studio Visualizer.42 The gp63
protein of L. major was obtained from the PDB database with
PDB ID 1LML; all water molecules were removed and
hydrogen atoms were added. On the other hand, the
protonation states of the surrounding histidine residues for
both proteins were assigned using PROPKA;43 they were
selected as neutral compared to those reported by Sutter et al.
(Figure 5).
4.2. Molecular Dynamics Simulation. Molecular dy-
namics (MD) simulations of 200 ns were performed for the
modeled protein and the template from L. panamensis and L.
major, respectively, using the GROMACS 2016.5 package;44 all
simulations were carried out using Amber99sb as a force
field.45 Both macromolecules were solvated by a cubic periodic
box in which each protein was solvated with TIP3P water
under periodic boundary conditions (PBCs).46 The system
was neutralized, and the ionic strength (0.1 mol L−1) of the
medium was adjusted by adding Na+ and Cl− ions, keeping the
number of particles constant. After these steps, energy
minimization of the systems was performed until convergence,
which was followed by equilibration with pressure and
temperature (NVT and NPT ensembles) kept constant at
300 K and 1.0 bar, respectively; equilibration periods were 1.0
ns, production runs were of 10 ns duration, and the V-rescale
thermostat and Parrinello−Rahman thermostat were used. The
LINCS47 and SETTLE48 algorithms were employed to
determine bond lengths of hydrogen atom distance constraints,
respectively, whereas long-range interactions were calculated
employing the particle-mesh Ewald (PME) method,49,50 used
to constrain the geometry of the water molecules. The
equilibrated system was subjected to the final MD production
run of 10 ns, applying the periodic boundary conditions
(PBCs) and integrating the equation of motion every 2 fs.
GROMACS and VMD51 software packages were used to
analyze the MD trajectories. Root-mean-square deviation
(RMSD) of Cα residues and root-mean-square fluctuation
(RMSF) were also calculated. In total, the production time was
200 ns for each system.
4.3. Ligand Database and Preparation. In total, 5470
drug-like compounds (chalcones, flavonoids, and biflavonoids)
were retrieved from the Super Natural II database52 as a single
file in spatial data file (SDF) format. This file was imported in
Open Babel53 and all ligand structures were converted into
PDB format. Then, the compounds were optimized with
density functional theory (DTF) at the B3LYP/6-31G level
using the Gaussian 09 package.54 Amphotericin B was obtained
from the PubChem database55 and employed as reference
molecules in molecular docking studies according to the
suggestions by Saukat et al.
4.4. Molecular Docking. Molecular docking was per-
formed using AutoDock Vina56 in PyRx 30.8 (virtual screening
tools).57 Then, the resulting collection of potential ligands was
docked into the leishmanolysin proteins. Hydrogen atoms
were added to all proteins, and partial atomic charges were
calculated. Initially, flexible-ligand docking was done. The grid
box size was set to 35 × 35 × 35 points with a spacing of 0.375
Å. For the calculation, 150 runs of the Lamarckian genetic
algorithm (LGA)58 with 25 000 000 evaluations and 270 000
generations were performed.
4.5. Validation. To validate docking, scoring functions
were assessed using different parameters like the area under the
curve (AUC), receiver operating characteristic (ROC) curve,
and enrichment factor (EF1%) according to Meekyum et al.59
A dataset of 176 molecules with strong, moderate, and weak
antileishmanial activity was employed to validate and to assess
the selectivity and sensibility of our methodology. A linear
correlation analysis was performed between the biological
activity (pIC50) and the affinity of flavonoids reported and the
calculated affinity values were, in addition, used for validation
of the virtual screening done by AutoDock Vina (Figure S6).
The statistical significance of the AUC value of different
models was evaluated with a p test with a 95% confidence limit.
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Orgańica Medicinal, Facultad de Ciencias Farmaceúticas,
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(25) Weniger, B.; Vonthron-Seńećheau, C.; Kaiser, M.; Brun, R.;
Anton, R. Comparative antiplasmodial, leishmanicidal and antitrypa-
nosomal activities of several biflavonoids. Phytomedicine 2006, 13,
176−180.
(26) Kumar, S.; Pandey, A. K. Chemistry and Biological Activities of
Flavonoids: An Overview. Sci. World J. 2013, 1−16.
(27) del Rayo Camacho, M.; Mata, R.; Castaneda, P.; Kirby, G. C.;
Warhurst, D. C.; Croft, S. L.; Phillipson, J. D. Bioactive compounds
from Celaenodendron mexicanum. Planta Med. 2000, 66, 463−468.
(28) Mbwambo, Z. H.; Kapingu, M. C.; Moshi, M. J.; Machumi, F.;
Apers, S.; Cos, P.; Ferreira, D.; Marais, J. P. J.; Berghe, D. V.; Maes,
L.; Vlietinck, A.; Pieters, L. Antiparasitic Activity of Some Xanthones
and Biflavonoids from the Root Bark of Garciniali vingstonei. J. Nat.
Prod. 2006, 69, 369−372.
(29) Jacob, V.; Hagai, T.; Soliman, K. Structure-activity relationships
of flavonoids. Curr. Org. Chem. 2011, 15, 2641−2657.
(30) Xiao, J.; Kai, G.; Yamamoto, K.; Chen, X. Advance in dietary
polyphenols as α-glucosidases inhibitors: a review on structure-activity
relationship aspect. Crit. Rev. Food Sci. Nutr. 2013, 53, 818−836.
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://dx.doi.org/10.1021/acsomega.0c01584
ACS Omega XXXX, XXX, XXX−XXX
H
(31) Yu, S.; Yan, H.; Zhang, L.; Shan, M.; Chen, P.; Ding, A.; Li, S. A
Review on the Phytochemistry, Pharmacology, and Pharmacokinetics
of Amentoflavone, a Naturally-Occurring Biflavonoid. Molecules 2017,
22, No. 299.
(32) Lin, Y.-M.; Flavin, M. T.; Cassidy, C. S.; Mar, A.; Chen, F.-C.
Biflavonoids as novel antituberculosis agents. Bioorg. Med. Chem. Lett.
2001, 11, 2101−2104.
(33) Wong, I. L. K.; Chan, K.-F.; Chan, T. H.; Chow, L. M. C.
Flavonoid Dimers as novel, potent antileishmanial agents. J. Med.
Chem. 2012, 55, 8891−8902.
(34) da Silva, E. R.; do Carmo Maquiaveli, C.; Magalhaes, P. P. The
leihmanicidal flavonols quercetin and quercetrin target Leishmania
(Leishmania) amazonensis arginase. Exp. Parasitol. 2012, 130, 183−
188.
(35) Kim, H. P.; Son, K. H.; Chang, H. W.; Kang, S. S. Effects of
naturally occurring flavonoids on inflammatory responses and their
action mechanisms. Nat. Prod. Sci. 2000, 6, 170−178.
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